Fred B. Craves, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 6,680 shares at $315.90 ($2.1M) on 2024-12-03, disclosed to the SEC on 2024-12-05.
Open-market sale of $2.1M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $315.21 | 3,080 | $971K | 46.1% |
| 2 | $315.21 | 3,080 | $971K | 46.1% |
| 3 | $315.90 | 520 | $164K | 7.8% |
| Total | $315.26 avg | 6,680 | $2.1M | 100% |
| Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |
| MDGL | SELL | 2019-12-13 | $253.1M | — | Filing → |